Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0004352 (
autism
)
32,579
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Duplications of 7q11.23, deleted in Williams-Beuren Syndrome, have been implicated in
autism
spectrum disorders (ASDs). A 1.5 Mb duplication was identified in one girl with severe expressive language deficits and anxiety among 1,142 ASD individuals screened for this duplication. Family-based association studies of Tag-SNPs in three genes (
STX1A
, CYLN2 and GTF2i) in two multiplex
autism
family cohorts revealed strong association of two GTF2i SNPs and their haplotype in Cohort 1 and the combined families. The risk alleles and haplotype were associated with severe problems in social interaction and excessive repetitive behaviors. Our findings suggest the GTF2i gene is important in the etiology of
autism
in individuals with this duplication and in non-duplication cases with severe social interaction problems and repetitive behaviors.
J
Autism
Dev Disord 2012 Jul
PMID:Association of GTF2i in the Williams-Beuren syndrome critical region with autism spectrum disorders. 2204 61
Multiple biological processes throughout development require intracellular vesicular trafficking, where the SNARE (soluble N-ethylmaleimide-sensitive factor (NSF) attachment protein (SNAP) receptors) complex plays a major role. The core proteins forming the SNARE complex are SNAP-25 (synaptosomal-associated protein 25), VAMP (vesicle-associated membrane protein) and Syntaxins, besides its regulatory proteins, such as Synaptotagmin. Genes encoding these proteins (SNAP25, VAMP1, VAMP2,
STX1A
, SYT1 and SYT2) have been studied in relation to psychiatric disorders susceptibility. Here, we review physiological aspects of SNARE complex and genetic association results reported for attention deficit hyperactivity disorder, both in children and adults,
autism
spectrum disorders, major depressive disorder, bipolar disorder and schizophrenia. Moreover, we included findings from expression, pharmacogenetics and animal model studies regarding these clinical phenotypes. The overall scenario depicted here suggests that the SNARE complex may exert distinct roles throughout development, with age-specific effects of genetic variants in psychiatric disorders. Such perspective should be considered in future studies regarding SNARE complex genes.
...
PMID:SNARE complex in developmental psychiatry: neurotransmitter exocytosis and beyond. 2685 28
We describe a 7-year-old male with high functioning
autism
spectrum disorder (ASD) and maternally-inherited rare missense variant of Synaptotagmin-like protein 4 (
SYTL4)
gene (Xq22.1; c.835C>T; p.Arg279Cys) and an unknown missense variant of Transmembrane protein 187 (
TMEM187
) gene (Xq28; c.708G>T; p. Gln236His). Multiple in-silico predictions described in our study indicate a potentially damaging status for both X-linked genes. Analysis of predicted atomic threading models of the mutant and the native SYTL4 proteins suggest a potential structural change induced by the R279C variant which eliminates the stabilizing Arg279-Asp60 salt bridge in the N-terminal half of the SYTL4, affecting the functionality of the protein's critical RAB-Binding Domain. In the European (Non-Finnish) population, the allele frequency for this variant is 0.00042. The
SYTL4
gene is known to directly interact with several members of the RAB family of genes, such as,
RAB27A, RAB27B, RAB8A,
and
RAB3A
which are known
autism
spectrum disorder genes. The
SYTL4
gene also directly interacts with three known
autism
genes:
STX1A
,
SNAP25
and
STXBP1.
Through a literature-based analytical approach, we identified three of five (60%)
autism
-associated serum microRNAs (miRs) with high predictive power among the total of 298 mouse Sytl4 associated/predicted microRNA interactions. Five of 13 (38%) miRs were differentially expressed in serum from ASD individuals which were predicted to interact with the mouse equivalent
Sytl
4 gene.
TMEM187
gene, like
SYTL4
, is a protein-coding gene that belongs to a group of genes which host microRNA genes in their introns or exons. The novel Q236H amino acid variant in the TMEM187 in our patient is near the terminal end region of the protein which is represented by multiple sequence alignments and hidden Markov models, preventing comparative structural analysis of the variant harboring region. Like
SYTL4
, the
TMEM187
gene is expressed in the brain and interacts with four known ASD genes, namely,
HCFC1; TMLHE; MECP2
; and
GPHN. TMM187
is in linkage with
MECP2
, which is a well-known determinant of brain structure and size and is a well-known
autism
gene. Other members of the
TMEM
gene family,
TMEM132E
and
TMEM132D
genes are associated with bipolar and panic disorders, respectively, while
TMEM231
is a known syndromic
autism
gene. Together,
TMEM187
and
SYTL4
genes directly interact with recognized important ASD genes, and their mRNAs are found in extracellular vesicles in the nervous system and stimulate target cells to translate into active protein. Our evidence shows that both these genes should be considered as candidate genes for
autism
. Additional biological testing is warranted to further determine the pathogenicity of these gene variants in the causation of
autism
.
...
PMID:High Functioning Autism with Missense Mutations in Synaptotagmin-Like Protein 4 (SYTL4) and Transmembrane Protein 187 (TMEM187) Genes: SYTL4- Protein Modeling, Protein-Protein Interaction, Expression Profiling and MicroRNA Studies. 3132 13
Members of the soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) family mediate membrane fusion processes associated with vesicular trafficking and autophagy. SNAREs mediate core membrane fusion processes essential for all cells, but some SNAREs serve cell/tissue type-specific exocytic/endocytic functions, and are therefore critical for various aspects of embryonic development. Mutations or variants of their encoding genes could give rise to developmental disorders, such as those affecting the nervous system and immune system in humans. Mutations to components in the canonical synaptic vesicle fusion SNARE complex (VAMP2,
STX1A
/B, and SNAP25) and a key regulator of SNARE complex formation MUNC18-1, produce variant phenotypes of
autism
, intellectual disability, movement disorders, and epilepsy. STX11 and MUNC18-2 mutations underlie 2 subtypes of familial hemophagocytic lymphohistiocytosis. STX3 mutations contribute to variant microvillus inclusion disease. Chromosomal microdeletions involving STX16 play a role in pseudohypoparathyroidism type IB associated with abnormal imprinting of the GNAS complex locus. In this short review, I discuss these and other SNARE gene mutations and variants that are known to be associated with a variety developmental disorders, with a focus on their underlying cellular and molecular pathological basis deciphered through disease modeling. Possible pathogenic potentials of other SNAREs whose variants could be disease predisposing are also speculated upon.
...
PMID:SNAREs and developmental disorders. 3295 7